Artykuły w czasopismach na temat „CHCHD10”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „CHCHD10”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Zhou, Wei, Dongrui Ma i Eng-King Tan. "Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications". Neuroscientist 26, nr 2 (16.09.2019): 170–84. http://dx.doi.org/10.1177/1073858419871214.
Pełny tekst źródłaLiu, Tian, Liam Wetzel, Zexi Zhu, Pavan Kumaraguru, Viraj Gorthi, Yan Yan, Mohammed Zaheen Bukhari i in. "Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion". Cells 12, nr 24 (7.12.2023): 2781. http://dx.doi.org/10.3390/cells12242781.
Pełny tekst źródłaImai, Yuzuru, Hongrui Meng, Kahori Shiba-Fukushima i Nobutaka Hattori. "Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia". International Journal of Molecular Sciences 20, nr 4 (20.02.2019): 908. http://dx.doi.org/10.3390/ijms20040908.
Pełny tekst źródłaGomez, Adriana Morales, Nathan Staff i Stephen C. Ekker. "288 Harnessing the potential of transcriptional adaptation as a mechanism for Amyotrophic lateral sclerosis". Journal of Clinical and Translational Science 7, s1 (kwiecień 2023): 86. http://dx.doi.org/10.1017/cts.2023.344.
Pełny tekst źródłaGomez, Adriana Morales, Nathan Staff i Stephen C. Ekker. "320 Genetic Compensation as a mechanism underlying patients with Rare ALS". Journal of Clinical and Translational Science 6, s1 (kwiecień 2022): 57. http://dx.doi.org/10.1017/cts.2022.178.
Pełny tekst źródłaGomez, Adriana Morales, Nathan Staff i Stephen C. Ekker. "393 Harnessing the potential of transcriptional adaptation as a mechanism for rare Amyotrophic lateral sclerosis". Journal of Clinical and Translational Science 8, s1 (kwiecień 2024): 117. http://dx.doi.org/10.1017/cts.2024.343.
Pełny tekst źródłaKeith, Julia L., Emily Swinkin, Andrew Gao, Samira Alminawi, Ming Zhang, Philip McGoldrick, Paul McKeever, Janice Robertson, Ekaterina Rogaeva i Lorne Zinman. "Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis". Neurology Genetics 6, nr 1 (13.01.2020): e394. http://dx.doi.org/10.1212/nxg.0000000000000394.
Pełny tekst źródłaMcCann, Emily P., Jennifer A. Fifita, Natalie Grima, Jasmin Galper, Prachi Mehta, Sarah E. Freckleton, Katharine Y. Zhang i in. "Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice". Journal of Neurology, Neurosurgery & Psychiatry 91, nr 2 (5.11.2019): 162–71. http://dx.doi.org/10.1136/jnnp-2019-321790.
Pełny tekst źródłaXiao, Yatao, Jianmin Zhang, Xiaoqiu Shu, Lei Bai, Wentao Xu, Ailian Wang, Aizhong Chen i in. "Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment". Human Molecular Genetics 29, nr 11 (2.07.2019): 1784–96. http://dx.doi.org/10.1093/hmg/ddz154.
Pełny tekst źródłaGrossman, Lawrence I., Neeraja Purandare, Rooshan Arshad, Stephanie Gladyck, Mallika Somayajulu, Maik Hüttemann i Siddhesh Aras. "MNRR1, a Biorganellar Regulator of Mitochondria". Oxidative Medicine and Cellular Longevity 2017 (2017): 1–12. http://dx.doi.org/10.1155/2017/6739236.
Pełny tekst źródłaStraub, Isabella R., Alexandre Janer, Woranontee Weraarpachai, Lorne Zinman, Janice Robertson, Ekaterina Rogaeva i Eric A. Shoubridge. "Loss of CHCHD10–CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS". Human Molecular Genetics 27, nr 1 (7.11.2017): 178–89. http://dx.doi.org/10.1093/hmg/ddx393.
Pełny tekst źródłaAyoubi, Riham, Walaa Alshafie, Kathleen Southern, Peter S. McPherson i Carl Laflamme. "The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence". F1000Research 12 (26.07.2023): 403. http://dx.doi.org/10.12688/f1000research.133479.2.
Pełny tekst źródłaAyoubi, Riham, Walaa Alshafie, Kathleen Southern, Peter S. McPherson i Carl Laflamme. "The identification of high-performing antibodies for Coiled-coil-helix-coiled-coil-helix domain containing protein 10 (CHCHD10) for use in Western Blot, immunoprecipitation and immunofluorescence". F1000Research 12 (14.04.2023): 403. http://dx.doi.org/10.12688/f1000research.133479.1.
Pełny tekst źródłaHuang, Xiaoping, Beverly P. Wu, Diana Nguyen, Yi-Ting Liu, Melika Marani, Jürgen Hench, Paule Bénit i in. "CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10". Human Molecular Genetics 28, nr 2 (4.10.2018): 349. http://dx.doi.org/10.1093/hmg/ddy340.
Pełny tekst źródłaRubino, Elisa, Livia Brusa, Ming Zhang, Silvia Boschi, Flora Govone, Alessandro Vacca, Annalisa Gai i in. "Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease". Neurobiology of Aging 53 (maj 2017): 193.e7–193.e8. http://dx.doi.org/10.1016/j.neurobiolaging.2016.12.027.
Pełny tekst źródłaRubino, Elisa, Ming Zhang, Tiziana Mongini, Silvia Boschi, Liliana Vercelli, Alessandro Vacca, Flora Govone i in. "Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy". Neurobiology of Aging 66 (czerwiec 2018): 181.e1–181.e2. http://dx.doi.org/10.1016/j.neurobiolaging.2018.02.007.
Pełny tekst źródłaZhou, Wei, Dongrui Ma, Alfred Xuyang Sun, Hoang-Dai Tran, Dong-liang Ma, Brijesh K. Singh, Jin Zhou i in. "PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction". Human Molecular Genetics 28, nr 7 (29.11.2018): 1100–1116. http://dx.doi.org/10.1093/hmg/ddy413.
Pełny tekst źródłaKobayashi, Yuri, Shinya Kusakari, Hiroaki Suzuki i Masaaki Matsuoka. "Analysis of molecular mechanism underlying cell death induced by an ALS/FTD-causative gene CHCHD10, S59L-CHCHD10". Proceedings for Annual Meeting of The Japanese Pharmacological Society 92 (2019): 1—SS—71. http://dx.doi.org/10.1254/jpssuppl.92.0_1-ss-71.
Pełny tekst źródłaLiu, Yi-Ting, Xiaoping Huang, Diana Nguyen, Mario K. Shammas, Beverly P. Wu, Eszter Dombi, Danielle A. Springer, Joanna Poulton, Shiori Sekine i Derek P. Narendra. "Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations". Human Molecular Genetics 29, nr 9 (27.04.2020): 1547–67. http://dx.doi.org/10.1093/hmg/ddaa077.
Pełny tekst źródłaPurandare, Neeraja, Mallika Somayajulu, Maik Hüttemann, Lawrence I. Grossman i Siddhesh Aras. "The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction". Journal of Biological Chemistry 293, nr 17 (14.03.2018): 6517–29. http://dx.doi.org/10.1074/jbc.ra117.001073.
Pełny tekst źródłaMao, Chengyuan, Herui Wang, Haiyang Luo, Shuyu Zhang, Huisha Xu, Shuo Zhang, Jared Rosenblum i in. "CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I". Neurobiology of Aging 75 (marzec 2019): 38–41. http://dx.doi.org/10.1016/j.neurobiolaging.2018.10.020.
Pełny tekst źródłaHarjuhaahto, Sandra, Tiina S. Rasila, Svetlana M. Molchanova, Rosa Woldegebriel, Jouni Kvist, Svetlana Konovalova, Markus T. Sainio i in. "ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons". Neurobiology of Disease 141 (lipiec 2020): 104940. http://dx.doi.org/10.1016/j.nbd.2020.104940.
Pełny tekst źródłavan Rheenen, Wouter, Frank P. Diekstra, Leonard H. van den Berg i Jan H. Veldink. "Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?" Brain 137, nr 12 (10.10.2014): e313-e313. http://dx.doi.org/10.1093/brain/awu299.
Pełny tekst źródłaBrockmann, Sarah J., Axel Freischmidt, Patrick Oeckl, Kathrin Müller, Srinivas K. Ponna, Anika M. Helferich, Christoph Paone i in. "CHCHD10 mutations p.R15L and p.G66V cause motoneuron disease by haploinsufficiency". Human Molecular Genetics 27, nr 4 (5.01.2018): 706–15. http://dx.doi.org/10.1093/hmg/ddx436.
Pełny tekst źródłaZhou, Xiaoxia, Zhenhua Liu, Jifeng Guo, Qiying Sun, Qian Xu, Xinxiang Yan, Beisha Tang i Lifang Lei. "Identification of CHCHD10 variants in Chinese patients with Parkinson's disease". Parkinsonism & Related Disorders 47 (luty 2018): 96–97. http://dx.doi.org/10.1016/j.parkreldis.2017.12.002.
Pełny tekst źródłaXiao, Tingting, Bin Jiao, Weiwei Zhang, Chuzheng Pan, Jingya Wei, Xiaoyan Liu, Yafang Zhou, Lin Zhou, Beisha Tang i Lu Shen. "Identification of CHCHD10 Mutation in Chinese Patients with Alzheimer Disease". Molecular Neurobiology 54, nr 7 (30.08.2016): 5243–47. http://dx.doi.org/10.1007/s12035-016-0056-3.
Pełny tekst źródłaStraub, Isabella R., Woranontee Weraarpachai i Eric A. Shoubridge. "Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses". Human Molecular Genetics 30, nr 8 (22.03.2021): 687–705. http://dx.doi.org/10.1093/hmg/ddab078.
Pełny tekst źródłaChe, Xiangqian, i Gang Wang. "P3-130: GENETIC FEATURES OF MAPT , GRN , C9ORF72 CHCHD2 , CHCHD10 AND SIGMAR1 GENE MUTATIONS IN CHINESE PATIENTS WITH FRONTOTEMPORAL DEMENTIA". Alzheimer's & Dementia 15 (lipiec 2019): P980—P981. http://dx.doi.org/10.1016/j.jalz.2019.06.3158.
Pełny tekst źródłaLi, Xiao Ling, Shi Shu, Xiao Guang Li, Qing Liu, Fang Liu, Bo Cui, Ming Sheng Liu, Bin Peng, Li Ying Cui i Xue Zhang. "CHCHD10 is not a frequent causative gene in Chinese ALS patients". Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17, nr 5-6 (14.04.2016): 458–60. http://dx.doi.org/10.3109/21678421.2016.1170151.
Pełny tekst źródłaBannwarth, Sylvie, Samira Ait-El-Mkadem, Annabelle Chaussenot, Emmanuelle C. Genin, Sandra Lacas-Gervais, Konstantina Fragaki, Laetitia Berg-Alonso i in. "Reply: Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?" Brain 137, nr 12 (10.10.2014): e314-e314. http://dx.doi.org/10.1093/brain/awu300.
Pełny tekst źródłaPenttilä, Sini, Manu Jokela, Anna Maija Saukkonen, Jari Toivanen, Johanna Palmio, Janne Lähdesmäki, Satu Sandell i in. "CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients". Journal of Neurology, Neurosurgery & Psychiatry 88, nr 3 (3.11.2016): 272–77. http://dx.doi.org/10.1136/jnnp-2016-314154.
Pełny tekst źródłaTeyssou, Elisa, Laura Chartier, Mélanie Albert, Alexandra Bouscary, Jean-Christophe Antoine, Jean-Philippe Camdessanché, Francesco Rotolo i in. "Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients". Neurobiology of Aging 42 (czerwiec 2016): 218.e1–218.e3. http://dx.doi.org/10.1016/j.neurobiolaging.2016.03.022.
Pełny tekst źródłaPenttilä, S., M. Jokela, A. Saukkonen, J. Toivanen i B. Udd. "Occurrence of CHCHD10 mutations in Finnish patients with motor neuron disorder". Neuromuscular Disorders 25 (październik 2015): S224. http://dx.doi.org/10.1016/j.nmd.2015.06.143.
Pełny tekst źródłaShen, Shen, Ji He, Lu Tang, Nan Zhang i Dongsheng Fan. "CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China". Neurobiology of Aging 54 (czerwiec 2017): 214.e7–214.e10. http://dx.doi.org/10.1016/j.neurobiolaging.2017.02.011.
Pełny tekst źródłaJokela, Manu E., Juho Joutsa i Bjarne Udd. "Evolving neuromuscular phenotype in a patient with a heterozygous CHCHD10 p.G66V mutation". Journal of Neurology 263, nr 7 (13.05.2016): 1461–62. http://dx.doi.org/10.1007/s00415-016-8134-z.
Pełny tekst źródłaWoo, Jung A. A., Tian Liu, Courtney Penn, Emilio De Narvaez, Drew Maslar, Cenxiao Fang, Anusha Bukhari i in. "P4-090: Chchd10 Mutations Synergize with TDP-43 to Promote Neuronal Apoptosis". Alzheimer's & Dementia 12 (lipiec 2016): P1046—P1047. http://dx.doi.org/10.1016/j.jalz.2016.06.2179.
Pełny tekst źródłaBannwarth, Sylvie, Samira Ait-El-Mkadem, Annabelle Chaussenot, Emmanuelle C. Genin, Sandra Lacas-Gervais, Konstantina Fragaki, Laetitia Berg-Alonso i in. "A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement". Brain 137, nr 8 (13.06.2014): 2329–45. http://dx.doi.org/10.1093/brain/awu138.
Pełny tekst źródłaZhou, QingQing, YongPing Chen, QianQian Wei, Bei Cao, Ying Wu, Bi Zhao, RuWei Ou i in. "Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis". Molecular Neurobiology 54, nr 5 (7.04.2016): 3189–94. http://dx.doi.org/10.1007/s12035-016-9888-0.
Pełny tekst źródłaGladyck, Stephanie, Siddhesh Aras, Maik Hüttemann i Lawrence I. Grossman. "Regulation of COX Assembly and Function by Twin CX9C Proteins—Implications for Human Disease". Cells 10, nr 2 (20.01.2021): 197. http://dx.doi.org/10.3390/cells10020197.
Pełny tekst źródłaJohnson, Janel O., Shannon M. Glynn, J. Raphael Gibbs, Mike A. Nalls, Mario Sabatelli, Gabriella Restagno, Vivian E. Drory, Adriano Chiò, Ekaterina Rogaeva i Bryan J. Traynor. "Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis". Brain 137, nr 12 (26.09.2014): e311-e311. http://dx.doi.org/10.1093/brain/awu265.
Pełny tekst źródłaMartherus, Ruben S. R. M., Willem Sluiter, Erika D. J. Timmer, Sabina J. V. VanHerle, Hubert J. M. Smeets i Torik A. Y. Ayoubi. "Functional annotation of heart enriched mitochondrial genes GBAS and CHCHD10 through guilt by association". Biochemical and Biophysical Research Communications 402, nr 2 (listopad 2010): 203–8. http://dx.doi.org/10.1016/j.bbrc.2010.09.109.
Pełny tekst źródłaKusakari, Shinya, Yuri Kobayashi, Hiroaki Suzuki i Masaaki Matsuoka. "Analysis of molecular mechanism underlying cell death induced by an ALS/FTD-causative gene CHCHD10". Proceedings for Annual Meeting of The Japanese Pharmacological Society 95 (2022): 3—O—115. http://dx.doi.org/10.1254/jpssuppl.95.0_3-o-115.
Pełny tekst źródłaBannwarth, Sylvie, Samira Ait-El-Mkadem, Annabelle Chaussenot, Emmanuelle C. Genin, Sandra Lacas-Gervais, Konstantina Fragaki, Laetitia Berg-Alonso i in. "Reply: Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis". Brain 137, nr 12 (26.09.2014): e312-e312. http://dx.doi.org/10.1093/brain/awu267.
Pełny tekst źródłaLiu, Tian, Jung‐A A. Woo, Mohammed Zaheen Bukhari, Patrick LePochat, Ann Chacko, Maj‐Linda B. Selenica, Yan Yan i in. "CHCHD10‐regulated OPA1‐mitofilin complex mediates TDP‐43‐induced mitochondrial phenotypes associated with frontotemporal dementia". FASEB Journal 34, nr 6 (5.05.2020): 8493–509. http://dx.doi.org/10.1096/fj.201903133rr.
Pełny tekst źródłaPerrone, Federica, Hung Phuoc Nguyen, Sara Van Mossevelde, Matthieu Moisse, Anne Sieben, Patrick Santens, Jan De Bleecker i in. "Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients". Neurobiology of Aging 51 (marzec 2017): 177.e9–177.e16. http://dx.doi.org/10.1016/j.neurobiolaging.2016.12.008.
Pełny tekst źródłaChaussenot, Annabelle, Isabelle Le Ber, Sylvie Bannwarth, Samira Ait El Kadem, Annie Verschueren, Jean Pouget i Véronique Paquis-Flucklinger. "Preuve d’une origine mitochondriale pour les phénotypes SLA/DFT à travers l’identification d’un nouveau gène CHCHD10". Revue Neurologique 171 (kwiecień 2015): A209—A210. http://dx.doi.org/10.1016/j.neurol.2015.01.476.
Pełny tekst źródłaAjroud-Driss, S., F. Fecto, K. Ajroud i T. Siddique. "Mutations in the Nuclear Encoded Novel Mitochondrial Protein CHCHD10 Cause an Autosomal Dominant Mitochondrial Myopathy (S55.001)". Neurology 78, Meeting Abstracts 1 (22.04.2012): S55.001. http://dx.doi.org/10.1212/wnl.78.1_meetingabstracts.s55.001.
Pełny tekst źródłaMüller, Kathrin, Peter M. Andersen, Annemarie Hübers, Nicolai Marroquin, Alexander E. Volk, Karin M. Danzer, Thomas Meitinger, Albert C. Ludolph, Tim M. Strom i Jochen H. Weishaupt. "Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease". Brain 137, nr 12 (9.08.2014): e309-e309. http://dx.doi.org/10.1093/brain/awu227.
Pełny tekst źródłaFratter, C., E. Dombi, J. Carver, K. Sergeant, I. A. Barbosa, M. Hofer, M. Esiri i in. "Mitochondrial disease and lipid storage myopathy due to mutation in CHCHD10 or DNM1L and disordered mitochondrial dynamics". Neuromuscular Disorders 27 (marzec 2017): S21. http://dx.doi.org/10.1016/s0960-8966(17)30279-1.
Pełny tekst źródłaAjroud-Driss, Senda, Faisal Fecto, Kaouther Ajroud, Irfan Lalani, Sarah E. Calvo, Vamsi K. Mootha, Han-Xiang Deng i in. "Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy". neurogenetics 16, nr 1 (6.09.2014): 1–9. http://dx.doi.org/10.1007/s10048-014-0421-1.
Pełny tekst źródła